Home Medicine Development of reference intervals for serum alkaline phosphatase among adults in Southern China traced to the new IFCC reference measurement procedure
Article
Licensed
Unlicensed Requires Authentication

Development of reference intervals for serum alkaline phosphatase among adults in Southern China traced to the new IFCC reference measurement procedure

  • Liqiao Han , Jianbing Wang , Qiaoxuan Zhang , Peifeng Ke , Xiaobin Wu , Zemin Wan , Haibiao Lin , Ruili Zeng , Xianzhang Huang EMAIL logo and Junhua Zhuang EMAIL logo
Published/Copyright: September 30, 2015

Abstract

Background: Serum alkaline phosphatase (ALP) plays a critical role in the diagnosis of various diseases, and the establishment of relevant, reliable reference intervals (RI) is key to avoiding misdiagnoses. In 2011, IFCC published the new reference measurement procedure (RMP) for the determination of serum ALP in which one of the main modifications was the measuring temperature of the assay. Here, the new RMP was used to help establish RIs for serum ALP concentrations in healthy Chinese Han.

Methods: Volunteer individuals in Guangdong province, China (n=1622) were screened by questionnaire and laboratory testing for eligibility as a reference. Blood (20 mL) was collected and samples were measured by the Roche Modular system using the new RMP for the serum ALP compatible method. Partitioning of values by gender and/or age was evaluated with a standard normal deviate test after removing outliers. A simple non-parametric method for a two-sided 95% distribution of reference values was calculated.

Results: Serum ALP concentrations were obtained from the cohort of eligible reference individuals (n=658). The RI for serum ALP in males age 18–79 years was 48–131 U/L. Females were partitioned into two age groups based on statistical analysis, 18–49 years and 50–79 years, and the RIs derived were 40–106 U/L and 57–159 U/L, respectively.

Conclusions: RIs for serum ALP for Chinese Han individuals in between the ages of 18 and 79 years were determined and required partitioning due to the higher ALP values of females age 50–79 years.


Corresponding authors: Xianzhang Huang and Junhua Zhuang, Department of Laboratory Science, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, P. R. China, Phone: +86-20-81887233-32908, E-mail: ;

References

1. Schumann G, Klauke R, Canalias F, Bossert-Reuther S, Frank PF, Gella FJ, et al. IFCC Primary reference procedures for the Measurement of catalytic Activity Concentrations of Enzymes at 37 °C. Part 9: Reference procedure for the measurement of catalytic concentration of Alkaline Phosphatase. Clin Chem Lab Med 2011;49:1439–46.10.1515/CCLM.2011.621Search in Google Scholar PubMed

2. Tietz NW, Rinker AD, Shaw LM. IFCC methods for the measurement of catalytic concentration of enzymes. Part 5. IFCC method for alkaline phosphatase (orthophosphoric-monoester phosphohydrolase. Alkaline optimum.EC3.1.3.1). J Clin Chem Clin Biochem 1983;21:731–48.Search in Google Scholar

3. Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Martensson A, et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 2004;64:271–84.10.1080/00365510410006324Search in Google Scholar PubMed

4. Health Ministry of China. Reference intervals for common clinical biochemistry tests – Part 1: Serum alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and γ-glutamyltransferase. WS/T 404.1-2002. Published in 2012.12.25. Implemented in 2013.08.01.Search in Google Scholar

5. Panteghini M, Ceriotti F, Schumann G, Siekmann L. Establishing a reference system in clinical enzymology. Clin Chem Lab Med 2001;39:795–800.10.1515/CCLM.2001.131Search in Google Scholar PubMed

6. China National Accreditation Service for Conformity Assessment (CNAS). http://219.238.178.49/BaseInfo.asp?Id=ML00002Search in Google Scholar

7. Clinical and Laboratory Standards Institute (CLSI). User verification of performance for precision and trueness; Approved guideline, 2nd edition. Wayne, PA: CLSI, 2008. CLSI document EP15-A2.Search in Google Scholar

8. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). RELA-IFCC External Quality assessment scheme for Reference Laboratories in Laboratory Medicine. Available at: http://www.dgkl-rfb.de:81/4Daction/g_search_RELA?selectAnalyte=AP&submitplot=show+result+plot&session_id=00000000000000000000&cur_year=2012&LabCode=065&checkboxLIM=with_limits. Accessed: 20 Dec 2014.Search in Google Scholar

9. Liqiao H, Jianbing W, Yun L, Qiaoxuan Z, Songbai Z, Haibiao L, et al. Application of new reference procedure for ALP measurement in the clinical laboratory. Clin Lab 2015;61:445–52.Search in Google Scholar

10. Clinical and Laboratory Standards Institute (CLSI). Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline, 3rd ed. Wayne, PA: CLSI, 2010. CLSI document EP28-A3c.Search in Google Scholar

11. Harris EK, Boyd JC. On dividing reference data into subgroups to produce separate reference ranges. Clin Chem 1990;36:265–70.10.1093/clinchem/36.2.265Search in Google Scholar

12. Stromme JH, Rustad P, Steensland H, Theodorsen L, Urdal P. Reference intervals for eight enzymes in blood of adult females and males measured in accordance with the International Federation of Clinical Chemistry reference system at 37 oC: part of the Nordic Reference Interval Project. Scand J Clin Lab Invest 2004;64:371–84.10.1080/00365510410002742Search in Google Scholar PubMed

13. Asare GA, Ezekiel NN, Nkumpoi T, Amoah AG. Reference intervals for common biochemical analytes in serum and plasma of a random adult population in the Greater Accra Region of Ghana. Clin Lab 2012;58:687–93.10.7754/Clin.Lab.2011.110Search in Google Scholar

Received: 2015-7-28
Accepted: 2015-8-26
Published Online: 2015-9-30
Published in Print: 2016-4-1

©2016 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Macroprolactin: searching for a needle in a haystack?
  4. Review
  5. Laboratory medicine in the new healthcare environment
  6. Opinion Paper
  7. Developing GRADE outcome-based recommendations about diagnostic tests: a key role in laboratory medicine policies
  8. EFLM Survey
  9. Accreditation process in European countries – an EFLM survey
  10. Genetics and Molecular Diagnostics
  11. HB Puerta del Sol [HBA1:c.148A>C], HB Valdecilla [HBA2:c.3G>T], HB Gran Vía [HBA2:c.98T>G], HB Macarena [HBA2:c.358C>T] and HB El Retiro [HBA2:c.364_366dupGTG]: description of five new hemoglobinopathies
  12. General Clinical Chemistry and Laboratory Medicine
  13. A candidate reference method using ICP-MS for sweat chloride quantification
  14. Quantification of hemoglobin A1c by off-line HPLC separation and liquid chromatography-tandem mass spectrometry: a modification of the IFCC reference measurement procedure
  15. Comparison between B·R·A·H·M·S PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients and established reference methods – a prospective multinational trial
  16. Evaluation of a hand-held blood gas analyzer for rapid determination of blood gases, electrolytes and metabolites in intensive care setting
  17. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms
  18. A possible cause of the variable detectability of macroprolactin by different immunoassay systems
  19. A multicenter comparison of whole blood vitamin B6 assays
  20. Analytical and clinical performance of the new Fujirebio 25-OH vitamin D assay, a comparison with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and three other automated assays
  21. Development and validation of a 2nd tier test for identification of purine nucleoside phosphorylase deficiency patients during expanded newborn screening by liquid chromatography-tandem mass spectrometry
  22. A cross-sectional study of biomarkers of exposure and effect in smokers and moist snuff consumers
  23. Reference Values and Biological Variations
  24. Pediatric reference value distributions and covariate-stratified reference intervals for 29 endocrine and special chemistry biomarkers on the Beckman Coulter Immunoassay Systems: a CALIPER study of healthy community children
  25. Development of reference intervals for serum alkaline phosphatase among adults in Southern China traced to the new IFCC reference measurement procedure
  26. Birth season predicts the values of red blood cell distribution width (RDW) in adulthood
  27. Cardiovascular Diseases
  28. Cardiovascular risk stratification in hemodialysis patients in the era of highly sensitive troponins: should we choose between hs-troponin I and hs-troponin T?
  29. A standardised FACS assay based on native, receptor transfected cells for the clinical diagnosis and monitoring of β1-adrenergic receptor autoantibodies in human heart disease
  30. Infectious Diseases
  31. The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases
  32. Letters to the Editor
  33. Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia
  34. Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia: a reply
  35. STORE (Sample Tracking: Organization, Refrigeration and Expansion): a project in a clinical laboratory perspective
  36. Control materials for immunochromatographic strip used for α-thalassemia screening
  37. Comparison of a 10- vs. 15-min centrifugation time for chemical and immunochemical assays and impact on turnaround time in a hospital laboratory
  38. Pre-analytical phase in cryoglobulin (CRG) detection: an alternative method for sample transport
  39. The efficacy of an internet-based e-learning system using the CellaVision Competency Software for continuing professional development
  40. Clinical examinations after the Fukushima disaster: a case report of Soma General Hospital
  41. Non-fasting plasma glucose concentration in blood donors
  42. Analytical evaluation of a second generation assay for chromogranin A; a dual-site study
  43. UBE3A, c.1347_1348delGA: a mutation in question
Downloaded on 30.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2015-0732/html
Scroll to top button